About
This medication is a fixed-dose combination of Sitagliptin and a higher strength of Metformin, often denoted as "Forte," specifically indicated for the treatment of type 2 diabetes mellitus. Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, functions by preventing the breakdown of incretin hormones, thereby enhancing glucose-dependent insulin secretion from pancreatic beta cells and suppressing glucagon release from alpha cells. Metformin, a biguanide, exerts its primary effects by reducing hepatic glucose production, decreasing intestinal glucose absorption, and improving insulin sensitivity in peripheral tissues. The synergistic action of these two agents, particularly with the increased Metformin dose, provides a robust and comprehensive approach to glycemic control, addressing multiple pathophysiological pathways of type 2 diabetes. It is typically used as an adjunct to diet and exercise when monotherapy is insufficient.
Uses
- Treatment of type 2 diabetes mellitus.
- When lower doses of Metformin or Sitagliptin are insufficient.
- As an adjunct to diet and exercise.
- To achieve optimal glycemic control in adults.
Directions For Use
Take this medication orally, usually twice daily with meals, or as directed by your physician, to minimize gastrointestinal upset.
Benefits
- Provides robust blood glucose lowering.
- Combines two effective mechanisms of action.
- Significant reduction in HbA1c levels.
- Potential for modest weight reduction.
- Improved insulin sensitivity.
- Convenient fixed-dose combination for enhanced adherence.
Side Effects
- Gastrointestinal upset (nausea, diarrhea, vomiting)
- Abdominal discomfort
- Metallic taste
- Headache
- Nasopharyngitis
- Upper respiratory tract infection
- Lactic acidosis (rare, serious, Metformin-related)
- Vitamin B12 deficiency (with prolonged Metformin use)
- Joint pain
- Skin rash
- Fatigue
- Dizziness
Safety Measures
- Alcohol - Avoid excessive alcohol intake due to the increased risk of lactic acidosis, a serious complication associated with Metformin.
- Pregnancy - Not generally recommended during pregnancy. Insulin is often the preferred treatment for diabetes in pregnant women. Consult a doctor.
- Breastfeeding - Both active ingredients are excreted in breast milk. A decision should be made to discontinue nursing or the drug, considering the importance of the drug to the mother.
- Liver - Metformin is contraindicated in severe hepatic impairment due to the heightened risk of lactic acidosis. Caution with Sitagliptin in liver disease.
- Kidney - Metformin is contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m²). Sitagliptin also requires dose adjustment based on renal function.
- Lung - Exercise caution in patients with conditions causing hypoxia (e.g., severe respiratory failure) as these can predispose to lactic acidosis.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!